Stelios Papadopoulos serves as Executive at SGX PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Stelios Papadopoulos has executed 157 insider transactions totaling $32.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 12, 2025 involved selling 100,000 shares valued at $4.4M.
Stelios Papadopoulos currently holds 1,189,228 shares of SGX PHARMACEUTICALS, INC. (SGXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stelios Papadopoulos has been a net seller of SGXP stock. They have purchased $8.8M and sold $23.7M worth of shares.
Stelios Papadopoulos's most recent insider trade was on Nov 12, 2025, when they sold 100,000 shares at $43.55 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 20, 2024 | EXEL | $240.2K | Sale | 11,437 | $21.00 | Discretionary |
| May 20, 2024 | EXEL | $228.7K | Option Exercise | 11,686 | $19.57 | Discretionary |
| Mar 14, 2024 | RGLS | $400.0K | Award | 250,000 | $1.60 | Discretionary |
| Jun 1, 2023 | EXEL | $0 | Award | 20,718 | $N/A | Discretionary |
| Apr 13, 2023 | RGLS | $200.0K | Award | 222,198 | $0.90 | Discretionary |
| Jun 15, 2022 | BIIB | $0 | Award | 2,255 | $N/A | Discretionary |
| May 26, 2022 | EXEL | $0 | Award | 19,575 | $N/A | Discretionary |
| Feb 22, 2022 | EXEL | $1.7M | Sale | 84,515 | $19.56 | Discretionary |
| Nov 30, 2021 | RGLS | $800.0K | Award | 2,222,222 | $0.36 | Discretionary |
| Jul 1, 2021 | BIIB | $0 | Award | 1,275 | $N/A | Discretionary |
| May 27, 2021 | EXEL | $0 | Award | 16,424 | $N/A | Discretionary |
| May 11, 2021 | EXEL | $135.2K | Option Exercise | 40,000 | $3.38 | Discretionary |
| May 11, 2021 | EXEL | $136.9K | Sale | 5,473 | $25.01 | Discretionary |
| May 11, 2021 | EXEL | $126.9K | Sale | 5,075 | $25.00 | Discretionary |
| May 11, 2021 | EXEL | $252.0K | Option Exercise | 40,000 | $6.30 | Discretionary |
| May 11, 2021 | EXEL | $125.2K | Option Exercise | 40,000 | $3.13 | Discretionary |
| May 11, 2021 | EXEL | $255.0K | Sale | 10,222 | $24.95 | Discretionary |
| Dec 4, 2020 | RGLS | $499.9K | Award | 793,528 | $0.63 | Discretionary |
| Dec 4, 2020 | RGLS | $499.9K | Award | 793,528 | $0.63 | Discretionary |
| Nov 24, 2020 | EUCR | $0 | Other | 255,094 | $N/A | Discretionary |
| Jun 3, 2020 | BIIB | $0 | Award | 1,470 | $N/A | Discretionary |
| May 21, 2020 | EXEL | $0 | Award | 15,538 | $N/A | Discretionary |
| May 13, 2020 | EXEL | $703.0K | Option Exercise | 120,791 | $5.82 | Discretionary |
| May 8, 2020 | EXEL | $88.8K | Option Exercise | 15,000 | $5.92 | Discretionary |
| May 8, 2020 | EXEL | $137.4K | Option Exercise | 30,000 | $4.58 | Discretionary |
| May 8, 2020 | EXEL | $1.2M | Sale | 45,000 | $25.84 | Discretionary |
| Feb 3, 2020 | RGLS | $0 | Conversion | 846,320 | $N/A | Discretionary |
| Jun 19, 2019 | BIIB | $0 | Award | 1,905 | $N/A | Discretionary |